Ken Doig

669 total citations
11 papers, 478 citations indexed

About

Ken Doig is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Ken Doig has authored 11 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 4 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Ken Doig's work include Cancer Genomics and Diagnostics (8 papers), Genetic factors in colorectal cancer (4 papers) and Genomics and Rare Diseases (2 papers). Ken Doig is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Genetic factors in colorectal cancer (4 papers) and Genomics and Rare Diseases (2 papers). Ken Doig collaborates with scholars based in Australia, Italy and France. Ken Doig's co-authors include David D.L. Bowtell, Sián Fereday, Swetansu Pattnaik, Elizabeth L. Christie, Sarah‐Jane Dawson, Andrew Fellowes, Jason Li, Stephen B. Fox, David M. Thomas and Stephen Q. Wong and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Pathology.

In The Last Decade

Ken Doig

10 papers receiving 472 citations

Peers

Countries citing papers authored by Ken Doig

Since Specialization

Citations

This map shows the geographic impact of Ken Doig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Doig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Doig more than expected).

Fields of papers citing papers by Ken Doig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Doig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Doig. The network helps show where Ken Doig may publish in the future.

Co-authorship network of co-authors of Ken Doig

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Doig. A scholar is included among the top collaborators of Ken Doig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Doig. Ken Doig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Preliminary phase 1 results of INCB161734, a novel oral Kirsten rat sarcoma (KRAS) G12D inhibitor, as monotherapy or in combination with chemotherapy for advanced/metastatic pancreatic duct adenocarcinoma (PDAC). 2026 ·Journal of Clinical Oncology ·Zev A. Wainberg, Jason T. Henry, (unknown), (unknown), (unknown), (unknown), (unknown), Shigehisa Kitano, (unknown), (unknown), (unknown), Philippe A. Cassier, (unknown), (unknown), (unknown), (unknown), (unknown), Aidan G. Gilmartin, Xiaohua Gong, Ken Doig	0
2	Sensitive NPM1 Mutation Quantitation in Acute Myeloid Leukemia Using Ultradeep Next-Generation Sequencing in the Diagnostic Laboratory 2018 ·Archives of Pathology & Laboratory Medicine ·Piers Blombery, Kate Jones, Ken Doig, Georgina L. Ryland, Michelle McBean, Ella R. Thompson, Costas K. Yannakou, David Westerman	7
3	Exploring the feasibility and utility of exome‐scale tumour sequencing in a clinical setting 2018 ·Internal Medicine Journal ·Belinda Lee, Ben Tran, Arthur Hsu, Graham R. Taylor, Stephen B. Fox, Andrew Fellowes, (unknown), Jennifer Mooi, Jayesh Desai, Ken Doig, Paul G. Ekert, Clara Gaff, (unknown), Anne Hamilton, Paul A. James, Andrew W. Roberts, Ray Snyder, Paul Waring, Grant A. McArthur	3
4	Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory 2017 ·Annals of Hematology ·Rishu Agarwal, Piers Blombery, Michelle McBean, Kate Jones, Andrew Fellowes, Ken Doig, Cecily Forsyth, David Westerman	14
5	Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer 2017 ·Journal of Clinical Oncology ·Elizabeth L. Christie, Sián Fereday, Ken Doig, Swetansu Pattnaik, Sarah‐Jane Dawson, David D.L. Bowtell	148
6	Circulating tumor DNA (ctDNA) to track responses and to capture the genomic heterogeneity of metastatic melanoma. 2016 ·Journal of Clinical Oncology ·Shahneen Sandhu, Stephen Q. Wong, Ismael A. Vergara, Jeanette Raleigh, Jason Callahan, Sarah Ftouni, Athena Hatzimihalis, Devbarna Sinha, Ken Doig, Andrew J. Colebatch, (unknown), Carleen Cullinane, David Gyorki, Damien Kee, Benjamin Brady, Mark Shackleton, Anthony T. Papenfuss, Rodney J. Hicks, Grant A. McArthur, Sarah‐Jane Dawson	1
7	“Cancer 2015”: A Prospective, Population-Based Cancer Cohort—Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic 2015 ·Journal of Personalized Medicine ·John P. Parisot, Heather Thorne, Andrew Fellowes, Ken Doig, Mark Lucas, John J. McNeil, Brett Doble, Alexander Dobrovic, Thomas John, Paul A. James, Lara Lipton, David M. Ashley, Theresa Hayes, Paul J. McMurrick, Gary Richardson, Paula Lorgelly, Stephen B. Fox, David M. Thomas	8
8	Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing 2014 ·BMC Medical Genomics ·Stephen Q. Wong, Jason Li, Angela Tan, Ravikiran Vedururu, Jia‐Min Pang, Hongdo Do, Jason Ellul, Ken Doig, Anthony Bell, Grant A. McArthur, Stephen B. Fox, David M. Thomas, Andrew Fellowes, John P. Parisot, Alexander Dobrovic, (unknown)	192
9	Bioinformatics Pipelines for Targeted Resequencing and Whole-Exome Sequencing of Human and Mouse Genomes: A Virtual Appliance Approach for Instant Deployment 2014 ·PLoS ONE ·Jason Li, Maria Doyle, Isaam Saeed, Stephen Q. Wong, Victoria Mar, David L. Goode, Franco Caramia, Ken Doig, Georgina L. Ryland, Ella R. Thompson, Sally M. Hunter, Saman Halgamuge, Jason Ellul, Alexander Dobrovic, Ian Campbell, Anthony T. Papenfuss, Grant A. McArthur, Richard W. Tothill	18
10	Studying Cancer Genomics Through Next-Generation DNA Sequencing and Bioinformatics 2014 ·Methods in molecular biology ·Maria Doyle, Jason Li, Ken Doig, Andrew Fellowes, Stephen Q. Wong	11
11	Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary 2013 ·The Journal of Pathology ·Richard W. Tothill, Jason Li, Linda Mileshkin, Ken Doig, (unknown), Prue A. Cowin, Andrew Fellowes, Timothy Semple, Stephen B. Fox, Keith Byron, Adam Kowalczyk, David M. Thomas, Penelope Schofield, David D.L. Bowtell	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact